MedTrace Logo

Bioimpedance Analysis in Chronic Heart Failure

NCT02662439 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2017-06-01

No results posted yet for this study

Summary

The aim of this study is to investigate whether the objective measurement of fluid overload by bioimpedance analysis (Body Composition Monitor-BCM) in patient with acute decompensated heart failure would improve the diuretic therapy.

Conditions

Interventions

DEVICE

Body Composition Monitor (BCM)

In the experimental group, the diuretic therapy adjusted according to the result of the BCM analysis.

Sponsors & Collaborators

  • Peter Studinger

    lead OTHER

Principal Investigators

  • Peter Studinger, MD, PhD · First Department of Medicine, Semmelweis University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-12-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02662439 on ClinicalTrials.gov